Nebenwirkungsmanagement Bei Der Behandlung Mit Bevacizumab Plus Interferon Alfa-2a

Best Practice Onkologie - Germany
doi 10.1007/bf03359734
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Springer Science and Business Media LLC


Related search